Genetically engineered tumor vaccines.
Pardoll
D M
DM
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
D000276:Adjuvants, Immunologic; D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology*; D000954:Antigens, Surface / Q000235:genetics / Q000276:immunology; D018122:B7-1 Antigen; D016207:Cytokines / Q000235:genetics; D005805:Genes, MHC Class I; D005802:Genes, MHC Class II; D006801:Humans; D007108:Immune Tolerance; D016233:Immunotherapy, Active / Q000379:methods*; D051379:Mice; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*; D014162:Transfection; D014614:Vaccines, Synthetic / Q000276:immunology
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D018122:B7-1 Antigen; D016207:Cytokines; D014614:Vaccines, Synthetic